Foto del docente

Filippo Basagni

Assegnista di ricerca

Dipartimento di Farmacia e Biotecnologie

Tutor didattico

Dipartimento di Farmacia e Biotecnologie

Pubblicazioni

vai alle Pubblicazioni

Pubblicazioni antecedenti il 2004

  • Basagni F., Lanni C., Minarini A., Rosini M., Lights and shadows of electrophile signaling:
    focus on the Nrf2-Keap1 pathway.
    Future medicinal chemistry,  04/2019 [Article]
  • M. L. Di Paolo, M. Cervelli, P. Mariottini, A. Leonetti, F. Polticelli, M. Rosini, A. Milelli, F. Basagni, R. Venerando, E. Agostinelli, A. Minarini, Exploring the activity of polyamine analogues on polyamine and spermineoxidase: methoctramine, a potent and selective inhibitor of polyamine oxidase. Journal of Enzyme Inhibition and Medicinal Chemistry 2019, 34 (1), 740-752 [Article]
  • Basagni F., Caporaso R., Bartolini M., Iurlo M., Marcaccio M., Minarini A., Rosini M. Pro-electrophilic compounds as pharmacologic tools for investigating the amyloidogenic pathway in alzheimer’s disease. XVIII GdC ER 2018 [Poster]
  • Catanzaro M., Fagiani F., Basagni F., Govoni S., Racchi M., Rosini M., Lanni C. Nature-inspired hybrids as multi-pharmacological agents: focus on BDNF cortisol-induced reduction in human neuroblastoma cells. More than Neurons 2018 [Poster]
  • Bongarzone S., Basagni F., Sementa T., Sing N., Gakpetor C, Faugeras V., Bordoloy J., Gee AD., Development of [18F]FAMTO: A novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands. Nuclear Medicine and Biology, Nov. 2018. [Article]
  • Basagni F., Targeting the amyloidogenic pathway in Alzheimer’s disease: focus on cathecol-based derivatives. ESMEC 2018. [Poster]
  • Basagni F., Bongarzone S., Sementa T., Gakpetor C, Sing N., Bordoloy J., Faugeras V., Gee AD., Novel 18F-labelled Metomidate analogue for targeting CYP11B1-CYP11B2 – Towards a new PET radiotracer for a more accurate diagnosis and personalised treatments of aldosteronoma-mediated hypertension. UK PET Chemistry Meeting 2017. [Oral presentation]

Ultimi avvisi

Al momento non sono presenti avvisi.